Is bluebird bio, Inc. (BLUE) a Buy, Sell, or Hold?
NASDAQ : BLUE
bluebird bio, Inc. — Competitors
$4.97 USD
$0 (0.0%)
- Volume
- 1.25M
- Average Volume
- 576.32K
- Market Capitalization
- $48.67M
- P/E Ratio
- -0.20
- Dividend Yield
- 0.00%
- Price Target
- $12.50
- Year High
- $28.60
- Year Low
- $3.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
BLUE vs. The Competition
| Properties | BLUE | ALVR | ERYP | GRNA |
|---|---|---|---|---|
| Market Cap | $48.67M | $49.48M | $47.38M | $45.43M |
| Shares Outstanding | $9.79M | $5.04M | $60.75M | $151.68M |
| P/E Ratio | -0.2 | -1.89 | -92.35 | -0.24 |
| EPS | -24.84 | -1.86 | -0.01 | -1.27 |
| Day Low | 4.97 | 9.55 | 0.78 | 0.2993 |
| Day High | 4.97 | 10.32 | 0.84 | 0.304 |
| Year Low | 3.2 | 7.96 | 0.3 | 0.177 |
| Year High | 28.6 | 24.15 | 1.472 | 5.9 |
| Average Price 50 | 4.4228 | 9.72533 | 0.859266 | 0.26908 |
| Average Price 200 | 7.50735 | 14.55053 | 0.74327415 | 0.853885 |
| Volume | 1.25M | 9402 | 3205 | 143.17K |
| Average Volume | - | - | - | - |